JP2020512385A5 - - Google Patents

Download PDF

Info

Publication number
JP2020512385A5
JP2020512385A5 JP2019553971A JP2019553971A JP2020512385A5 JP 2020512385 A5 JP2020512385 A5 JP 2020512385A5 JP 2019553971 A JP2019553971 A JP 2019553971A JP 2019553971 A JP2019553971 A JP 2019553971A JP 2020512385 A5 JP2020512385 A5 JP 2020512385A5
Authority
JP
Japan
Prior art keywords
antibody
immunoamphiphile
immune
fusion protein
binding peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019553971A
Other languages
English (en)
Japanese (ja)
Other versions
JP7229169B2 (ja
JP2020512385A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/024721 external-priority patent/WO2018183417A1/en
Publication of JP2020512385A publication Critical patent/JP2020512385A/ja
Publication of JP2020512385A5 publication Critical patent/JP2020512385A5/ja
Priority to JP2022168138A priority Critical patent/JP2023011689A/ja
Application granted granted Critical
Publication of JP7229169B2 publication Critical patent/JP7229169B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019553971A 2017-03-30 2018-03-28 生体高分子の精製のための超分子高アフィニティタンパク質結合系 Active JP7229169B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022168138A JP2023011689A (ja) 2017-03-30 2022-10-20 生体高分子の精製のための超分子高アフィニティタンパク質結合系

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762478886P 2017-03-30 2017-03-30
US62/478,886 2017-03-30
PCT/US2018/024721 WO2018183417A1 (en) 2017-03-30 2018-03-28 A supramolecular high affinity protein-binding system for purification of biomacromolecules

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022168138A Division JP2023011689A (ja) 2017-03-30 2022-10-20 生体高分子の精製のための超分子高アフィニティタンパク質結合系

Publications (3)

Publication Number Publication Date
JP2020512385A JP2020512385A (ja) 2020-04-23
JP2020512385A5 true JP2020512385A5 (https=) 2021-05-06
JP7229169B2 JP7229169B2 (ja) 2023-02-27

Family

ID=63678187

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019553971A Active JP7229169B2 (ja) 2017-03-30 2018-03-28 生体高分子の精製のための超分子高アフィニティタンパク質結合系
JP2022168138A Pending JP2023011689A (ja) 2017-03-30 2022-10-20 生体高分子の精製のための超分子高アフィニティタンパク質結合系

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022168138A Pending JP2023011689A (ja) 2017-03-30 2022-10-20 生体高分子の精製のための超分子高アフィニティタンパク質結合系

Country Status (6)

Country Link
US (3) US11359005B2 (https=)
EP (1) EP3601362A4 (https=)
JP (2) JP7229169B2 (https=)
KR (2) KR102660861B1 (https=)
CN (2) CN110741017B (https=)
WO (1) WO2018183417A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3601362A4 (en) * 2017-03-30 2020-12-16 The Johns Hopkins University HIGH AFFINITY PROTEIN SUPRAMOLECULAR BINDING SYSTEM FOR BIOMACROMOLECULES PURIFICATION
JP7379323B2 (ja) * 2017-08-18 2023-11-14 ザ・ジョンズ・ホプキンス・ユニバーシティ タンパク質精製のための超分子フィラメント集合体
US20210130395A1 (en) * 2018-05-11 2021-05-06 William Marsh Rice University Proximity induced site-specific antibody conjugation
CN114225020B (zh) * 2021-12-31 2023-05-02 暨南大学 一种ova淀粉样蛋白原纤维及其制备方法与应用

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5476996A (en) 1988-06-14 1995-12-19 Lidak Pharmaceuticals Human immune system in non-human animal
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US6673986B1 (en) 1990-01-12 2004-01-06 Abgenix, Inc. Generation of xenogeneic antibodies
US6075181A (en) 1990-01-12 2000-06-13 Abgenix, Inc. Human antibodies derived from immunized xenomice
US6150584A (en) 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
EP1690934A3 (en) 1990-01-12 2008-07-30 Abgenix, Inc. Generation of xenogeneic antibodies
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US6172197B1 (en) 1991-07-10 2001-01-09 Medical Research Council Methods for producing members of specific binding pairs
US5877397A (en) 1990-08-29 1999-03-02 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5770429A (en) 1990-08-29 1998-06-23 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5874299A (en) 1990-08-29 1999-02-23 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
ATE300615T1 (de) 1990-08-29 2005-08-15 Genpharm Int Transgene mäuse fähig zur produktion heterologer antikörper
US6300129B1 (en) 1990-08-29 2001-10-09 Genpharm International Transgenic non-human animals for producing heterologous antibodies
US6255458B1 (en) 1990-08-29 2001-07-03 Genpharm International High affinity human antibodies and human antibodies against digoxin
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5814318A (en) 1990-08-29 1998-09-29 Genpharm International Inc. Transgenic non-human animals for producing heterologous antibodies
US5789650A (en) 1990-08-29 1998-08-04 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
ES2341666T3 (es) 1991-12-02 2010-06-24 Medimmune Limited Produccion de autoanticuerpos de repertorios de segmentos de anticue rpos expresados en la superficie de fagos.
CA2124967C (en) 1991-12-17 2008-04-08 Nils Lonberg Transgenic non-human animals capable of producing heterologous antibodies
CA2161351C (en) 1993-04-26 2010-12-21 Nils Lonberg Transgenic non-human animals capable of producing heterologous antibodies
US6013763A (en) * 1996-06-04 2000-01-11 Genentech, Inc. Peptide variants of protein A
IL148079A0 (en) 1999-08-24 2002-09-12 Medarex Inc Human ctla-4 antibodies and compositions containing the same
CN1487996B (zh) 2000-11-30 2010-06-16 米德列斯公司 用于生产人类抗体的转基因转染色体啮齿动物
WO2006123829A1 (ja) * 2005-05-17 2006-11-23 Sapporo Medical University PAP2aに対する抗体ならびにその診断的および治療的使用
US8551781B2 (en) * 2009-11-19 2013-10-08 The Regents Of The University Of California Vault complexes for facilitating biomolecule delivery
EP3601362A4 (en) * 2017-03-30 2020-12-16 The Johns Hopkins University HIGH AFFINITY PROTEIN SUPRAMOLECULAR BINDING SYSTEM FOR BIOMACROMOLECULES PURIFICATION
JP7379323B2 (ja) * 2017-08-18 2023-11-14 ザ・ジョンズ・ホプキンス・ユニバーシティ タンパク質精製のための超分子フィラメント集合体

Similar Documents

Publication Publication Date Title
JP2020512385A5 (https=)
JP2014221801A5 (https=)
JP2021038246A (ja) 分泌様免疫グロブリンを含む組成物
CN1160126C (zh) 败血症治疗用免疫吸附剂
JP7379323B2 (ja) タンパク質精製のための超分子フィラメント集合体
KR20220129003A (ko) 재조합 단백질 제조 공정으로부터 불순물을 감소시키기 위한 방법
US5605691A (en) Immunologically active proteins from inclusion bodies
US6464851B1 (en) Removal of biological contaminants
US11066452B2 (en) Antibody binding nanofibrils
US12383884B2 (en) Polyamide medium for purifying protein-containing solution and method for producing polyamide medium
US7077942B1 (en) Removal of biological contaminants
JP3719958B2 (ja) 体外免疫吸着装置
JP2003532739A (ja) トリ抗体の分離
CN105612178B (zh) 利用包含含蛋白膜囊泡的抗原组合物制备多克隆抗体的方法
EP2696895A1 (en) IMMUNOAFFINITY SEPARATION MATERIALS COMPRISING ANTI-IgE ANTIBODY DERIVATIVES
JP2012214408A (ja) 澄明液中に分散した不純物凝集体を除去することによるタンパク質の精製方法
JP3689888B2 (ja) 卵黄より選択的にlgYおよびlgY(ΔFc)抗体アイソフォームを分離する方法
WO2014054046A1 (en) Ordered reversible fibrils, aggregates and multimers of proteins and uses thereof
CN104073502B (zh) 人脑钠肽的中和性基因工程抗体3c1及其制备方法和应用
RU2304587C2 (ru) СПОСОБ СЕЛЕКТИВНОГО ВЫДЕЛЕНИЯ АНТИТЕЛ IgY ИЗ ЯИЧНОГО ЖЕЛТКА ПТИЦ ОТРЯДА ГУСЕОБРАЗНЫХ (ВАРИАНТЫ)
KR102198342B1 (ko) 항체 선별 방법 및 이를 이용한 항체 선별 시스템
JP2013001689A (ja) 卵黄からのIgY精製方法
AU769070B2 (en) Removal of biological contaminants
CN1463985A (zh) 自雁形目鸟类卵中选择性分离IgY抗体的方法及由此获得的IgY抗体
CN120608084A (zh) 一种新型hpv融合蛋白抗原的构建、制备方法及在制备多克隆卵黄抗体中的应用